Industry
Weltruza FDA Approval: What PMHNPs Need to Know
Weltruza, the first monthly subcutaneous olanzapine LAI, drops the 3-hour observation. What PMHNPs need on dosing, PDSS, candidates, and metabolic monitoring.
Real talk about psychopharmacology, clinical confidence, and the questions you don’t feel you can ask at work — from Lindsay and the Fellowship faculty.
More Articles
Weltruza, the first monthly subcutaneous olanzapine LAI, drops the 3-hour observation. What PMHNPs need on dosing, PDSS, candidates, and metabolic monitoring.
Secure checkout by Stripe. After you pay, we invite you to Skool, the app where we meet.